SubHero Banner
Text

Pifeltro™ (doravirine), Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) – Expanded indications

January 27, 2022, the FDA approved Merck’s Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate).

Download PDF